ClinicalTrials.Veeva

Menu

Breathing With a Facemask Exercise Performance

C

CereVu Medical

Status

Completed

Conditions

Pulmonary Disease, Chronic Obstructive

Treatments

Combination Product: CereVu Objective Dyspnea Score

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05633017
CIP5002

Details and patient eligibility

About

This study will determine the dyspnea response in chronic lung disease volunteers during treadmill walking with and without added inspiratory resistance. This study will also determine the level of dyspnea and exercise sense of effort in individuals walking on a treadmill when elevations occur. Comparisons will be made of a participant's exercise response with and without increased inspiratory resistance. In this study, exercise performance will be analyzed based on physiological and perceptual measures. The participant will undergo two sessions: one session will be a standard exercise walking test without an inspiratory resistance; the other session will be the same standard exercise walking test while breathing with an inspiratory resistance equal to a N95 facemask (R=10-15 cmH2O/L/sec). Performance will be determined by physiological measures. Perception will be determined by scores based on numerical scales and automatically with the forehead Vitality remote monitoring sensor.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Former pulmonary rehabilitation patients that are now participating in maintenance exercise classes
  • Males and females with an age range of 18 years or older
  • Subjects must be able to walk on treadmill for multiple sessions

Exclusion criteria

  • The subjects in each experiment will be recruited for a distribution of gender, ethnicity and age

Trial design

52 participants in 2 patient groups

Pulmonary Rehab Patients
Description:
Patients who attend respiratory therapy at John Muir Pulmonary Rehab facility
Treatment:
Combination Product: CereVu Objective Dyspnea Score
Control
Description:
Healthy adults, 18+
Treatment:
Combination Product: CereVu Objective Dyspnea Score

Trial contacts and locations

1

Loading...

Central trial contact

Johnathan Gasson; Cindy Cayou, RCP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems